Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - TOTAL RECEIVABLES
Total Receivables FOLD - Amicus Therapeutics, Inc.
87.6 M
LAST VALUE
28.99%
2 YEAR CAGR
31.89%
5 YEAR CAGR
55.17%
10 YEAR CAGR